Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 292,538 | 336,111 | 350,129 | 402,765 | 576,596 |
| Marketable Securities | 445,096 | 523,871 | 437,645 | 544,609 | 471,924 |
| Receivables | 1,991 | 2,911 | 4,920 | 16,555 | 17,467 |
| Inventories | 38,419 | 38,445 | 33,665 | 23,708 | 13,808 |
| Income taxes - deferred | 25,909 | 26,177 | 27,675 | N/A | N/A |
| Other current assets | 103,729 | 94,571 | 123,576 | 84,688 | 78,252 |
| TOTAL | $928,041 | $1,042,619 | $977,610 | $1,076,980 | $1,161,040 |
| Non-Current Assets | |||||
| PPE Net | 368,503 | 304,031 | 264,537 | 202,817 | 154,894 |
| Investments And Advances | 763,659 | 671,842 | 700,565 | 507,289 | 400,315 |
| Intangibles | 0 | 0 | 9,280 | 0 | 0 |
| Other Non-Current Assets | 98,374 | 99,915 | 107,697 | 122,346 | 115,784 |
| TOTAL | $1,230,536 | $1,075,788 | $1,082,079 | $832,452 | $670,993 |
| Total Assets | $2,158,577 | $2,118,407 | $2,059,689 | $1,909,432 | $1,832,033 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 51,440 | 1,807 | 3,886 | 4,059 | 3,053 |
| Accrued Expenses | N/A | 55,143 | 51,607 | 41,743 | 32,312 |
| Other current liabilities | 806 | N/A | N/A | N/A | N/A |
| TOTAL | $52,246 | $57,665 | $56,225 | $47,402 | $37,065 |
| Non-Current Liabilities | |||||
| Long Term Debt | 876,641 | 871,345 | 866,205 | 861,185 | 856,165 |
| Deferred Revenues | N/A | 715 | 732 | 1,600 | 1,700 |
| aiOther Non-Current Liabilities | 29,559 | 25,856 | 27,569 | 4,747 | 3,666 |
| TOTAL | $906,200 | $900,374 | $893,774 | $869,094 | $863,005 |
| Total Liabilities | $958,446 | $958,039 | $949,999 | $916,496 | $900,070 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 155,449 | 155,076 | 154,677 | 153,033 | 152,679 |
| Common Shares | 79 | 78 | 78 | 77 | 77 |
| Retained earnings | 333,142 | 304,376 | 263,176 | 218,582 | 180,142 |
| Other shareholders' equity | 3,024 | 3,698 | 3,764 | 3,391 | 1,679 |
| TOTAL | $1,200,131 | $1,160,368 | $1,109,690 | $992,936 | $931,963 |
| Total Liabilities And Equity | $2,158,577 | $2,118,407 | $2,059,689 | $1,909,432 | $1,832,033 |